Research Directory

Rare Diseases AbbVie-Shire merger could be a new beginning

Read more

Gently pushing the accelerator in cancer

Read more

Genomic Research - What IP filings show about the major players

Read more

What next for the EMA's transparency policy?

Read more

Stocks mostly stable amid the fireworks

Read more

Commentary: Alphabodies - working inside the cell

Read more

Targeted drugs are changing cancer development

Read more

Interview with Nextech Invest: Funding the new era in oncology

Read more

Commentary: Why checkpoint inhibitors need help

Read more

How outcomes measures can improve healthcare

Read more